Increased Dosage of Tumor Suppressors Limits the Tumorigenicity of iPS Cells Without Affecting Their Pluripotency

Aging Cell - United Kingdom
doi 10.1111/j.1474-9726.2011.00754.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Deletion of Btg1 Induces Prmt1-Dependent Apoptosis and Increased Stemness in SHH-Type Medulloblastoma Cells Without Affecting Tumor Frequency

Frontiers in Oncology
Cancer ResearchOncology
2020English

Tumorigenicity-Associated Characteristics of Human iPS Cell Lines

PLoS ONE
Multidisciplinary
2018English

Dinaciclib Potently Suppresses McL-1 and Selectively Induces the Cell Death in Human iPS Cells Without Affecting the Viability of Cardiac Tissue

Scientific Reports
Multidisciplinary
2017English

PU.1 Binding to the P53 Family of Tumor Suppressors Impairs Their Transcriptional Activity

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Method to Synchronize Cell Cycle of Human Pluripotent Stem Cells Without Affecting Their Fundamental Characteristics

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2019English

Expression of Mouse Mammary Tumor Virus Superantigen Accelerates Tumorigenicity of Myeloma Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Identification of the Downstream Promoter Targets of Smad Tumor Suppressors in Human Breast Cancer Cells

2004English

Isolation of Single-Base Genome-Edited Human iPS Cells Without Antibiotic Selection

Nature Methods
BiochemistryBiotechnologyCell BiologyMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy